View in EDS HTML Full Text PDF Full Text

MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.

Saved in:
Bibliographic Details
Title: MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
Authors: Farnsworth DA; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada., Inoue Y; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada., Johnson FD; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada., de Rappard-Yuswack G; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada., Lu D; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada., Shi R; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada., Ma LIJ; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada., Mattar MS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Somwar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Unni AM; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Lockwood WW; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada. wlockwood@bccrc.ca.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, Canada. wlockwood@bccrc.ca.
Source: NPJ precision oncology [NPJ Precis Oncol] 2022 Nov 23; Vol. 6 (1), pp. 88. Date of Electronic Publication: 2022 Nov 23.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36418460
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Farnsworth+DA%22">Farnsworth DA</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Inoue+Y%22">Inoue Y</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Johnson+FD%22">Johnson FD</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22de+Rappard-Yuswack+G%22">de Rappard-Yuswack G</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Lu+D%22">Lu D</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Shi+R%22">Shi R</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Ma+LIJ%22">Ma LIJ</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Mattar+MS%22">Mattar MS</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Somwar+R%22">Somwar R</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ladanyi+M%22">Ladanyi M</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Unni+AM%22">Unni AM</searchLink>; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lockwood+WW%22">Lockwood WW</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada. wlockwood@bccrc.ca.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, Canada. wlockwood@bccrc.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2022 Nov 23; Vol. 6 (1), pp. 88. <i>Date of Electronic Publication: </i>2022 Nov 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36418460
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-022-00328-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 88
    Titles:
      – TitleFull: MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Farnsworth DA
      – PersonEntity:
          Name:
            NameFull: Inoue Y
      – PersonEntity:
          Name:
            NameFull: Johnson FD
      – PersonEntity:
          Name:
            NameFull: de Rappard-Yuswack G
      – PersonEntity:
          Name:
            NameFull: Lu D
      – PersonEntity:
          Name:
            NameFull: Shi R
      – PersonEntity:
          Name:
            NameFull: Ma LIJ
      – PersonEntity:
          Name:
            NameFull: Mattar MS
      – PersonEntity:
          Name:
            NameFull: Somwar R
      – PersonEntity:
          Name:
            NameFull: Ladanyi M
      – PersonEntity:
          Name:
            NameFull: Unni AM
      – PersonEntity:
          Name:
            NameFull: Lockwood WW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 11
              Text: 2022 Nov 23
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1